Vitalant Research Institute, San Francisco, California, USA.
Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Transfusion. 2023 Oct;63(10):1872-1884. doi: 10.1111/trf.17515. Epub 2023 Aug 29.
Individual risk assessment allows donors to be evaluated based on their own behaviors. Study objectives were to assess human immunodeficiency virus (HIV) risk behaviors in men who have sex with men (MSM) and estimate the proportion of the study population who would not be deferred for higher risk HIV sexual behaviors.
Cross-sectional survey and biomarker assessment were conducted in eight U.S. cities. Participants were sexually active MSM interested in blood donation aged 18-39 years, assigned male sex at birth. Participants completed surveys during two study visits to define eligibility, and self-reported sexual and HIV prevention behaviors. Blood was drawn at study visit 1 and tested for HIV and the presence of tenofovir, one of the drugs in oral HIV pre-exposure prophylaxis (PrEP). Associations were assessed between HIV infection status or HIV PrEP use and behaviors, including sex partners, new partners, and anal sex.
A total of 1566 MSM completed the visit 1 questionnaire and blood draw and 1197 completed the visit 2 questionnaire. Among 1562 persons without HIV, 789 (50.4%) were not taking PrEP. Of those not taking PrEP, 66.2% reported one sexual partner or no anal sex and 69% reported no new sexual partners or no anal sex with a new partner in the past 3 months.
The study found that questions were able to identify sexually active, HIV-negative MSM who report lower risk sexual behaviors. About a quarter of enrolled study participants would be potentially eligible blood donors using individual risk assessment questions.
个体风险评估允许根据供者自身行为进行评估。本研究旨在评估男男性行为者(MSM)中的人类免疫缺陷病毒(HIV)风险行为,并估计研究人群中因高风险 HIV 性行为而被推迟献血的比例。
在八个美国城市进行了横断面调查和生物标志物评估。研究对象为年龄在 18-39 岁、有过性行为且对献血感兴趣的、出生时被分配为男性的 MSM。参与者在两次研究访视期间完成问卷调查以确定其是否符合条件,并报告性行为和 HIV 预防行为。在研究访视 1 时采集血液样本,用于检测 HIV 和替诺福韦(一种口服 HIV 暴露前预防药物)的存在。分析了 HIV 感染状况或 HIV 暴露前预防药物使用与性行为(包括性伴侣、新伴侣和肛交)之间的关联。
共有 1566 名 MSM 完成了访视 1 的问卷调查和血液采集,1197 名完成了访视 2 的问卷调查。在 1562 名未感染 HIV 的人中,有 789 人(50.4%)未服用暴露前预防药物。在未服用暴露前预防药物的人中,66.2%报告仅有一名性伴侣或没有肛交,69%报告在过去 3 个月内没有新的性伴侣或与新伴侣没有肛交。
本研究发现,这些问题能够识别出报告低风险性行为的活跃、HIV 阴性的 MSM。大约四分之一的入组研究参与者可能符合使用个体风险评估问题的潜在献血者条件。